4002 Stock Overview
Acquires, manages, operates, and maintains hospitals, medical centers, drug stores, medicine warehouses, and pharmacies in the Kingdom of Saudi Arabia. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for 4002 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Mouwasat Medical Services Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ر.س92.10 |
| 52 Week High | ر.س144.00 |
| 52 Week Low | ر.س83.50 |
| Beta | 0.45 |
| 1 Month Change | 7.34% |
| 3 Month Change | -2.13% |
| 1 Year Change | -23.38% |
| 3 Year Change | -9.71% |
| 5 Year Change | 121.93% |
| Change since IPO | 1,181.39% |
Recent News & Updates
Recent updates
The Returns At Mouwasat Medical Services (TADAWUL:4002) Aren't Growing
Dec 12
Do Mouwasat Medical Services' (TADAWUL:4002) Earnings Warrant Your Attention?
Sep 30The Returns At Mouwasat Medical Services (TADAWUL:4002) Aren't Growing
Sep 12Mouwasat Medical Services Company's (TADAWUL:4002) Popularity With Investors Is Clear
Aug 06Does Mouwasat Medical Services (TADAWUL:4002) Deserve A Spot On Your Watchlist?
Jul 01Mouwasat Medical Services Company's (TADAWUL:4002) Popularity With Investors Is Clear
Apr 23Here's Why We Think Mouwasat Medical Services (TADAWUL:4002) Might Deserve Your Attention Today
Mar 18Shareholder Returns
| 4002 | SA Healthcare | SA Market | |
|---|---|---|---|
| 7D | 2.3% | 0.8% | -0.5% |
| 1Y | -23.4% | -4.9% | -5.8% |
Return vs Industry: 4002 underperformed the SA Healthcare industry which returned -4.9% over the past year.
Return vs Market: 4002 underperformed the SA Market which returned -5.8% over the past year.
Price Volatility
| 4002 volatility | |
|---|---|
| 4002 Average Weekly Movement | 3.4% |
| Healthcare Industry Average Movement | 4.6% |
| Market Average Movement | 3.7% |
| 10% most volatile stocks in SA Market | 7.7% |
| 10% least volatile stocks in SA Market | 2.1% |
Stable Share Price: 4002 has not had significant price volatility in the past 3 months compared to the SA market.
Volatility Over Time: 4002's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1974 | n/a | Nasser Sultan Al-Subaie | www.mouwasat.com |
Mouwasat Medical Services Company acquires, manages, operates, and maintains hospitals, medical centers, drug stores, medicine warehouses, and pharmacies in the Kingdom of Saudi Arabia. It operates a network of hospitals in Dammam, Jubail, Madinah, Khobar, Qatif, and Riyadh that provides medical services. The company also operates skin care centers, which offer laser, cosmetic dermatological, reconstructive surgery, plastic surgery, weight loss, and other medical cosmetic services; a fertility unit; eye center; and a bariatric surgery clinic, as well as long term care that enhances functional recovery.
Mouwasat Medical Services Company Fundamentals Summary
| 4002 fundamental statistics | |
|---|---|
| Market cap | ر.س18.42b |
| Earnings (TTM) | ر.س658.09m |
| Revenue (TTM) | ر.س2.90b |
28.0x
P/E Ratio6.4x
P/S RatioIs 4002 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4002 income statement (TTM) | |
|---|---|
| Revenue | ر.س2.90b |
| Cost of Revenue | ر.س1.55b |
| Gross Profit | ر.س1.35b |
| Other Expenses | ر.س688.11m |
| Earnings | ر.س658.09m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.29 |
| Gross Margin | 46.47% |
| Net Profit Margin | 22.72% |
| Debt/Equity Ratio | 22.0% |
How did 4002 perform over the long term?
See historical performance and comparisonDividends
1.9%
Current Dividend Yield53%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/31 20:28 |
| End of Day Share Price | 2025/01/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Mouwasat Medical Services Company is covered by 22 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jassim Al-Jubran | Aljazira Capital Company |
| Rim Ben Salah Gharbi | AlphaMena |
| Kais Kriaa | AlphaMena |